HBSAg 抗体
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| HBSAg 抗体 (Subtype ad/ay) (HRP) | Hepatitis B Virus (HBV) | 兔 Polyclonal |
|
|
|
| Recombinant HBSAg 抗体 | Hepatitis B Virus (HBV) | 绵羊 Monoclonal |
|
|
|
| HBSAg 抗体 (Subtype ad/ay) | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 (Subtype ad/ay) | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 (Subtype ad/ay) | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 (Peroxidase (POD)) | Hepatitis B Virus (HBV) | 兔 Polyclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 山羊 Polyclonal |
|
|
|
| HBSAg 抗体 (FITC) | Hepatitis B Virus (HBV) | 山羊 Polyclonal |
|
|
|
| HBSAg 抗体 (Peroxidase (POD)) | Hepatitis B Virus (HBV) | 山羊 Polyclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 兔 Polyclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 (FITC) | Hepatitis B Virus (HBV) | 兔 Polyclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
|
| HBSAg 抗体 (Subtype ad/ay) | Hepatitis B Virus (HBV) | 马 Polyclonal |
|
|
|
| HBSAg 抗体 (Subtype ad/ay) (Biotin) | Hepatitis A Virus (HAV) | 兔 Polyclonal |
|
|
|
| HBSAg 抗体 (Subtype ad/ay) (FITC) | Hepatitis B Virus (HBV) | 兔 Polyclonal |
|
|
|
| HBSAg 抗体 (Subtype ayw) (HRP) | Hepatitis B Virus (HBV) | 小鼠 Monoclonal |
|
|
- ELISA (ELISA: 所列应用)
- PrA (Protein Assay: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗原表位
- Subtype ad/ay
- ELISA (ELISA: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IA (Immunoassay: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- AP (Affinity Purification: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 绵羊
- 克隆形成能力
- Monoclonal
- 克隆
- MCHBS
- 标记
- unconjugated
- Fragment
- scFv fragment
- 蛋白类型
- Recombinant Antibody
- ELISA (ELISA: 所列应用)
- LF (Lateral Flow: 所列应用)
- RIA (Radioimmunoassay: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- BID40
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- Subtype ad/ay
- ELISA (ELISA: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- Subtype ad/ay
- ELISA (ELISA: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- Subtype ad/ay
- WB (Western Blotting: 所列应用)
- EIA (Enzyme Immunoassay: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Peroxidase (POD)
- 抗体亚型
- IgG
- Func (Functional Studies: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- WB (Western Blotting: 所列应用)
- EIA (Enzyme Immunoassay: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- Peroxidase (POD)
- 抗体亚型
- IgG
- Func (Functional Studies: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- ELISA (ELISA: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 马
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Subtype ad/ay
- ELISA (ELISA: 所列应用)
- 适用
- Hepatitis A Virus (HAV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗原表位
- Subtype ad/ay
- ELISA (ELISA: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗原表位
- Subtype ad/ay
- ELISA (ELISA: 所列应用)
- 适用
- Hepatitis B Virus (HBV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- Hs41
- 标记
- HRP
- 抗体亚型
- IgG1
- 抗原表位
- Subtype ayw
Latest Publications for our HBSAg 抗体
: "Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants." in: Frontiers in microbiology, Vol. 11, pp. 1653, (2020) (PubMed).
: "Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK ..." in: Molecular medicine reports, Vol. 18, Issue 5, pp. 4691-4699, (2019) (PubMed).
: "Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway." in: Free radical biology & medicine, Vol. 131, pp. 225-236, (2019) (PubMed).
: "Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress." in: Scientific reports, Vol. 8, Issue 1, pp. 3496, (2018) (PubMed).
: "Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy." in: BMC public health, Vol. 17, Issue 1, pp. 636, (2018) (PubMed).
: "Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection." in: Scientific reports, Vol. 7, pp. 45698, (2017) (PubMed).
: "Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer." in: Virus research, Vol. 235, pp. 86-95, (2017) (PubMed).
: "Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance." in: Nature communications, Vol. 8, Issue 1, pp. 2119, (2017) (PubMed).
: "Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice." in: Oncotarget, Vol. 8, Issue 32, pp. 52560-52570, (2017) (PubMed).